Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Elicio Therapeutics, Inc. (ELTX) had Free Cash Flow per Share of $-1.81 for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-10.08M |
|
-- |
|
-- |
|
$8.04M |
|
$-8.04M |
|
$-2.04M |
|
$-10.08M |
|
$-10.08M |
|
$-10.08M |
|
$-10.08M |
|
$-10.08M |
|
$-10.08M |
|
$-8.04M |
|
$-7.76M |
|
16.69M |
|
16.69M |
|
$-0.60 |
|
$-0.60 |
|
| Balance Sheet Financials | |
$21.46M |
|
$0.33M |
|
$6.82M |
|
$28.28M |
|
$6.51M |
|
$9.72M |
|
$17.95M |
|
$24.47M |
|
$3.82M |
|
$3.82M |
|
$3.82M |
|
17.26M |
|
| Cash Flow Statement Financials | |
$-30.16M |
|
-- |
|
$31.83M |
|
$19.49M |
|
$21.31M |
|
$1.82M |
|
$1.93M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.29 |
|
-- |
|
-- |
|
0.72 |
|
2.55 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-30.16M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-264.23% |
|
-264.23% |
|
-35.65% |
|
-74.49% |
|
$0.22 |
|
|
Free Cash Flow per Share |
$-1.81 |
$-1.81 |
|